Correspondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

.

Source: Expert Opinion on Therapeutic Targets - November 29, 2021 Category: Drugs & Pharmacology Authors: Dhriti Kaushik Ranjana Bhandari Anurag Kuhad Source Type: research